Akums Drugs & Pharmaceuticals Share Price Target 2025: Can It Reclaim ₹700?

Akums Drugs & Pharmaceuticals Share Price Target 2025: Can It Reclaim ₹700?

Akums Drugs & Pharmaceuticals is trading at ₹538.05 as of July 24, 2025. With a significant fall from its 52-week high of ₹1,175, can the stock bounce back by 2025? Let’s look at the latest technical analysis, support levels, and price forecast.

Current Stock Overview

  • Current Price: ₹538.05

  • Day Range: ₹537.00 – ₹545.25

  • 52-Week Range: ₹405.00 – ₹1,175.90

  • Market Cap: ₹8,280 Crore

  • P/E Ratio: ~24x

Akums Drugs & Pharmaceuticals Share Price Chart

Technical Analysis Summary

Trend Direction

  • Akums is in a consolidation phase, trading below key moving averages (50-day & 200-day).

  • The stock shows sideways movement with no clear breakout or breakdown yet.

Key Indicators

  • RSI (14): Near 50 – Suggests neutral momentum

  • MACD: Mixed signals, no strong momentum trend

  • Volume: Decreasing compared to previous weeks

Support & Resistance

  • Major Support: ₹530

  • Immediate Resistance: ₹577 – ₹582

  • Next Resistance: ₹608 – ₹642

Akums Share Price Target 2025

Scenario Target Price Range Outlook Description
Base Case ₹530 – ₹610 Likely range if sideways trend continues
Bullish Case ₹640 – ₹700 Breakout above ₹610 supported by strong earnings
Bearish Case ₹450 – ₹500 If ₹530 support breaks, may test lower levels

Growth Catalysts for Akums

  1. Strong Revenue Performance: FY25 income crossed ₹1,000 Cr with 15%+ YoY growth

  2. Contract Manufacturing Boom: Growing demand in CDMO services for pharma

  3. Capacity Expansion: New plants in Kotdwar and Haridwar for injectables & APIs

  4. Export Opportunities: Expansion in Africa, LATAM, and Middle East markets

  5. Analyst Rating: ICICI Securities gives a ‘Buy’ with a ₹710 target

Risks and Challenges

  • Below Key Moving Averages: Needs to break ₹610 to confirm trend reversal

  • Input Cost Volatility: Rising raw material prices may impact margins

  • Market Sentiment: FII selling and weak pharma outlook can weigh on price

  • Breakdown Risk: A drop below ₹530 may trigger sharp downside

Akums Drugs is currently in a neutral zone between ₹530–₹610.
If it sustains above ₹577 and breaks ₹610, a move toward ₹640–₹700 is possible in 2025.
However, a close below ₹530 could push the stock down to ₹450 levels.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *